Closing

1D

YTD

Market cap

-

52 week high

-

52 week low

-

Volume

-

Check if the stock is halal

Unlock Industry-grade Shariah Compliance for global stocks. See results from 5 major Shariah standards: AAOIFI, S&P, DJIM, FTSE and MSCI.

We provide unparalleled value and service.
Screened by AAOIFI Certified Shariah Advisor & Auditor.

Get started from just $3.99/month

Market cap

-

Analysts' Rating

-

Price Target (Mean)

-

Total Analysts

0

P/E

-

Operating Margin

-

Beta

-

Revenue Growth (Annual)

69.65%

52 week high

-

52 week low

-

Div. Yield

-

EPS Annual Growth

-

Note on Purification and Zakat

  • Purification and Zakat (for long-term investing) calculations are in USD per share and based on AAOIFI methodology. AAOIFI requires purification every financial period (e.g. quarterly). 
  • If you follow S&P Shariah’s Dividend-only purification, then remove the impure income % from the dividends you receive. No purification required for non-dividend paying stocks, according to S&P Shariah.
  • For Zakat, if you did not invest in a company from a long term perspective, then consider the shares as trading goods and give 2.5% of the total value if a year has passed on them. 

Company Profile

RTW Venture Fund Limited is a Guernsey-based closed-ended investment company. The Company’s investment objective is to generate risk-adjusted returns through investments in securities, both equity and debt, long and short, of companies with a focus on the pharmaceutical sector. The Company focuses on investing in life science, biopharmaceutical and medical technology companies. It intends to create a diversified portfolio of investments across a range of businesses, each pursuing the development of superior pharmacological or medical therapeutic assets to enhance the quality of life and/or extend patient life. It invests approximately 80 % of its gross assets in the biopharmaceutical sector and approximately 20 % of its gross assets in the medical technology sector. Its investment manager is RTW Investments, LP.